Bixiye
Xolremdi (mavorixafor) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 991 - 1000 ee natiijooyinka 3289
Bixiye
Xolremdi (mavorixafor) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024